Keyword: U.S. Supreme Court
Merck's appeal to the Supreme Court has drawn in the U.S. Solicitor General, and the outcome could reverberate across the pharmaceutical industry.
The Supreme Court is set to decide whether the controversial inter partes review process is constitutional.
J&J dropped a lawsuit accusing Samsung Bioepis of infringing patents on Remicade, a $5 billion med that now faces biosimilar rivals.
Johnson & Johnson has successfully challenged two talc verdicts and wiped away nearly $500 million in liabilities.
J&J has escaped a $72 million verdict in its ongoing talcum powder saga, the first reversal of its numerous losses.
It didn't take long for Congress to push back at Allergan's first-of-a-kind patent deal with the Saint Regis Mohawk Tribe.
A lawsuit alleges J&J has "blatantly lied" for decades about talc safety, accusing the company of participating in a conspiracy to conceal the truth.
Amgen has come up short in a legal attempt to defend blockbuster anemia med Epogen from a Pfizer biosim.
In one legal expert's view, Johnson & Johnson will continue to take a tough stand against thousands of talc cases.
A second Remicade biosimilar hit the U.S. market to take a larger slash at pricing.